ReShape Lifesciences Inc’s recently made public that its Chief Financial Officer STANKOVICH THOMAS unloaded Company’s shares for reported $12.0 on May 31 ’24. In the deal valued at $0.25 per share,48 shares were sold. As a result of this transaction, STANKOVICH THOMAS now holds 22,777 shares worth roughly $8655.26.
Price Performance Review of RSLS
On Monday, ReShape Lifesciences Inc [NASDAQ:RSLS] saw its stock jump 23.73% to $0.38. Over the last five days, the stock has lost -16.98%. ReShape Lifesciences Inc shares have fallen nearly -91.41% since the year began. Nevertheless, the stocks have fallen -95.97% over the past one year. While a 52-week high of $29.00 was reached on 01/13/25, a 52-week low of $0.30 was recorded on 04/09/25. SMA at 50 days reached $0.9578, while 200 days put it at $5.5820.
Levels Of Support And Resistance For RSLS Stock
The 24-hour chart illustrates a support level at 0.3395, which if violated will result in even more drops to 0.2958. On the upside, there is a resistance level at 0.4597. A further resistance level may holdings at 0.5362. The Relative Strength Index (RSI) on the 14-day chart is 42.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1404, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.97%. Stochastics %K at 1.24% indicates the stock is a buying.
How much short interest is there in ReShape Lifesciences Inc?
A steep rise in short interest was recorded in ReShape Lifesciences Inc stocks on 2025-03-31, growing by 0.22 million shares to a total of 0.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 0.47 million shares. There was a rise of 31.52%, which implies that there is a positive sentiment for the stock.
